Available Technologies   //   Inventor Portal

Get Started with the Polsky Center

Featured

Alnair Therapeutics Follows Polsky Path to String of Impressive Wins, $1M+ Funding Round

Read More
See All Podcasts
Alnair Therapeutics Follows Polsky Path to String of Impressive Wins, $1M+ Funding Round
1 / 1
Alnair Therapeutics Follows Polsky Path to String of Impressive Wins, $1M+ Funding Round
News //

AbbVie Joins UChicago to Talk Oncology Research, Ongoing Collaboration, and Opportunities for Expansion

The annual UChicago-AbbVie Research Symposium in August celebrated another successful year of the strategic partnership – bringing together academia and industry to exchange new ideas and drive innovation. The event…
Event //

AbbVie, University of Chicago Symposium to Showcase Latest Oncology Research Efforts

The UChicago-AbbVie Research Symposium celebrates another successful year of strategic partnership, showcasing select innovative research efforts in oncology. Taking place Friday, August 19, 2022, the symposium aims to stimulate…
Event //

‘You Need a Village’: Clinical Trial Leaders Discuss Collaborations, COVID, and Widening the Lens

Experts came together on Clinical Trials Day to discuss why early and frequent discussions among all stakeholders are necessary, how COVID forced the industry to think “more clearly and…
Event //

DeepTechU Day 3: Advice for Deep Tech Entrepreneurs, the Future of Immunotherapy, and Opportunities in Quantum

Day 3 of DeepTechU featured advice for entrepreneurs developing deep tech innovations, a look at the current and future immunotherapy market, and a Fireside Chat about growing the quantum…
Event //

DeepTechU Day 2: Securing VC Funding and Federal Grants that ‘Take on the Risk that the Private Market Cannot’

The second day of DeepTechU featured practical advice for deep tech startups seeking funding, including when to start conversations with venture capitalists and how to use federal government grants…
News //

AbbVie and UChicago Extend Collaboration to Support Preclinical Oncology Research

The University of Chicago and AbbVie have announced an extended collaboration agreement through 2025 to support preclinical oncology research. To date, the collaboration has led to novel insights related to…
News //

UChicago Advances Cancer Research Through Partnership with AbbVie

On campus and beyond, the University of Chicago community is constantly striving to innovate and drive discovery through research and development. In the field of oncology, there is no exception.…

Evelo Bioscience, a Biotech Company Based on UChicago-licensed Technology, Debuts on Nasdaq

Evelo is dedicated to improving the lives of patients globally through the development of a new modality of medicines called monoclonal microbials
News //

In Era of Research Cuts, Romance Blossoming Much Earlier Between Universities and Big Pharma

Engineering new pharmaceuticals is risky, achingly slow and astronomically expensive. While the estimates of how much it costs to get a drug into patients' hands vary and are often disputed,…
News //

AbbVie, U of C Choose First Batch of Cancer Research Projects

Pharmaceutical giant AbbVie and University of Chicago have picked their initial set of projects to research cancer, a deadly disease given a renewed focus under the Obama administration. They include…
News //

AbbVie, University of Chicago Collaborate to Advance Cancer Research

The University of Chicago and AbbVie, a global biopharmaceutical company, have entered into a five-year collaboration agreement designed to improve the pace of discovery and advance medical research in oncology…

This site uses cookies and other tracking technologies to assist with navigation and your ability to provide feedback, analyze your use of products and services, assist with our promotional and marketing efforts.

Accept